National HealthCare Co. (NHC) Director Sells $69,440.00 in Stock
National HealthCare Co. (NYSEMKT:NHC) Director James Paul Abernathy sold 1,000 shares of National HealthCare stock in a transaction dated Friday, November 18th. The stock was sold at an average price of $69.44, for a total transaction of $69,440.00. Following the completion of the sale, the director now owns 24,165 shares of the company’s stock, valued at approximately $1,678,017.60. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
Shares of National HealthCare Co. (NYSEMKT:NHC) traded down 0.4725% during midday trading on Monday, hitting $69.4901. 7,490 shares of the company traded hands. The stock has a market capitalization of $1.05 billion, a PE ratio of 20.4986 and a beta of 0.91. National HealthCare Co. has a 52 week low of $57.16 and a 52 week high of $70.12. The stock has a 50 day moving average of $65.86 and a 200-day moving average of $64.71.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 1st. Investors of record on Friday, December 30th will be issued a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.58%. The ex-dividend date is Wednesday, December 28th. National HealthCare’s dividend payout ratio (DPR) is currently 52.94%.
Separately, Macquarie raised shares of National HealthCare from an “underperform” rating to an “outperform” rating in a report on Thursday, September 22nd.
About National HealthCare
National HealthCare Corporation (NHC) is engaged in the operation of skilled nursing facilities with associated assisted living and independent living centers. The Company’s business activities include providing sub-acute skilled and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, senior living services, and home healthcare services.
Receive News & Stock Ratings for National HealthCare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare Co. and related stocks with our FREE daily email newsletter.